Who we are

GFE, established in 2005 by the German Red Cross, rapidly emerged as one of the leading entities in the field of virus detection through nucleic acid amplification technology (NAT). The founders of GFE are esteemed authorities in the realm of blood donation diagnostics, demonstrating a strong dedication to high-caliber research.

Their pivotal contributions during the early 1990’s were instrumental in the advancement of techniques and protocols that integrated NAT testing as a standard practice for screening blood donors in the testing facilities of the German Red Cross.

This innovative endeavor positioned GFE as one of the pioneering organizations globally to enhance blood safety significantly. GFE provides its clientele with NAT tests for all viruses pertinent to transfusions, employing cutting-edge technologies such as multi-dye and target-plexing methodologies, which offer exceptional sensitivity, specificity, and coverage against target mutations.

The company

is located within an Innovation and Technology Campus in Frankfurt am Main / Germany next to the Goethe University and the Max-Planck Institute.

The products

are designed and developed for the qualitative virus detection and blood screening applications striving for outstanding products and services for the Blood Transfusion Community.

Our vision

is increasing patient safety by providing first-rate diagnostic tests and cutting edge solutions for blood testing.

General Management

Dr. Petra Rehberger

CEO

Susanne Suoka

CFO

Shareholders

The Bavarian Red Cross is a member association and national association of the Federal Association “German Red Cross e.V.”.

Prof. Dr. med. Axel Seltsam

Ärztlicher Geschäftsführer

The DRK Blutspendedienst NSTOB results from the union of the national associations of the German Red Cross Lower Saxony, Saxony-Anhalt, Thuringia, Oldenburg and Bremen.

PD Dr. med. Oliver Meyer

Ärztlicher Geschäftsführer